Impact of morbid obesity in surgical management of endometrial cancer: surgical morbidity, clinical and pathological aspects

Objective: To evaluate the effect of body mass index (BMI) on clinical, surgical, pathologic features, and surgical morbidity in the management of patients with endometrial cancer.

Materials & methods: All endometrial cancer patients who were surgically treated in our institution between January 1, 2003 and January 1, 2006 were eligible for the study. Forty-two out of 60 patients were included in the analysis from our cancer database. The patients were divided into three groups: BMI < 30, BMI 30-40, BMI > 40. Statistical analysis was performed by SPSS for Windows (version 11; SPSS, Inc., Chicago, IL).

Results: Lymphadenectomy as part of surgical staging was performed in 90.5% of all patients. Although patients with a BMI > 40 were less likely to have positive lymph vascular space invasion (LVSI) (p = 0.042), chance of deep myometrial invasion and positive lymph nodes (18%) were the same as for patients with a BMI < 30. Patients with a BMI > 40 had statistically longer operating times when compared to patients with a BMI < 40 (p = 0.039). Wound separation rate was statistically higher in the morbidly obese patients (p = 0.01). Average number of lymph nodes removed, hospital days, intraoperative and overall postoperative complication rates did not differ among the three groups (p > 0.05).

Conclusions: This study confirms that comprehensive surgical staging can be performed adequately and safely in obese and morbidly obese endometrial cancer patients with no difference in length of hospital stay, intraoperative or postoperative complications. As a result adjuvant treatment of morbidly obese patients can be planned accordingly preventing under or over treatment.

Morbid obesity; Endometrial carcinoma; Surgical management; Lmphadenectomy

[1] Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E. et. al.: "Cancer statistics, 2004, CA". Cancer J. Clin., 2004, 54, 8.

[2] Baker T.R.: "Endometrial Carcinoma". In: Piver M.S. (ed.), "Handbook of Gynecologic Oncology". 2''edition, New York, Little, Brown and Company, 1995, 142.

[3] Anderson B., Connor J.P., Andrews J.I., Davis C.S., Buller R.E., Sorosky J.I. et al.: "Obesity and prognosis in endometrial cancer". Am. J. Obstet. Gynecol., 1996, 174, 1171.

[4] Bloss J.D., Berman M.L., Bloss L.P., Buller R.E.: "Use of vaginal hysterectomy for the management of Stage I endometrial cancer in the medically compromised patient". Gynecol. Oneal., 1991, 40, 74.

[5] Chan J.K., Lin Y.G., Monk B.J., Tewari K., Bloss J.D., Berman M.L.: "Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women". Obstet. Gynecol., 2001, 97, 707.

[6] Peters W.A. III, Andersen W.A., Thornton W.N. Jr., Morley G.W.: "The selective use of vaginal hysterectomy in the management of adenocarcinoma of the endometrium". Am. J. Obstet. Gynecol., 1983, 146, 285.

[7] "Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults". Arch. Intern. Med., 1998, 158, 1855.

[8] Bokhman J.V.: "Two pathogenetic types of endometrial carcinoma". Gynecol. Oneal., 1983, 15, 10.

[9] Abu-Abid S., Szold A., Klausner J.: "Obesity and cancer''. J. Med., 2002, 33, 73.

[10] Cowles T.A., Magrina J.F., Masterson B.J., Capen C.V.: "Comparison of clinical and surgical-staging in patients with endometrial carcinoma". Obstet. Gynecol., 1985, 66, 413.

[11] Eltabbakh G.H., Shamonki J., Mount S.L.: "Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors". Gynecol. Oneal., 2005, 99, 309.

[12] Shim J.U., Rose P.G., Reale F.R., Soto H., Tak W.K., Hunter R.E.: ''Accuracy of frozen-section山agnosis at surgery in clinical Stage I and II endometrial carcinoma". Am. J. Obstet. Gynecol., 1992, 166, 1335.

[13] Ben-Shachar I., Pavelka J., Cohn D.E., Copeland L.J., Ramirez N., Manolitsas T. et. al.: "Surgical staging for patients presenting with grade 1 endometrial carcinoma". Obstet. Gynecol., 2005, 105, 487.

[14] Kilgore L.C., Partridge E.E., Alvarez R.D., Austin J.M., Shingleton H.M., Noojin F. et. al.: "Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling". Gynecol. Oneal., 1995, 56, 29.

[15] Fanning J.: "Long-term survival of intermediate risk endometrial cancer (Stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy". Gynecol. Oneal., 2001, 82, 371.

[16] Mohan D.S., Samuels M.A., Selim M.A., Shalodi A.O., Ellis R.J., Samuels J.R. et al.: "Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma". Gynecol. Oneal., 1998, 70, 165.

[17] Cragun J., Havrilesky L.J., Calingaert B., Synan I., Secord A.A., Soper J.T. et al.: "Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer". J. Clin. Oneal., 2005, 23, 16.

[18] Wright J.D., Powell M.A., Herzog T.J., Mutch D.G., Rader J.S., Gao F. et. al.: " Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms". Gynecol. Oneal., 2004, 94, 436.

[19] Nguyen T.V., Petereit D.G.: "High-dose-rate brachytherapy for medically inoperable Stage I endometrial cancer". Gynecol. Oneal., 1998, 71, 196.

[20] Everett E., Tamimi H., Greer B., Swisher E., Paley P., Mandel L.: "The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer". Gynecol. Oneal., 2003, 90, 150.

[21] Pavelka J.C., Ben-Shachar I., Fowler J.M. Ramirez N.C., Copeland L.J., Eaton L.A.: "Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients". Gynecol. Oneal., 2004, 95, 588.

[22] Morrow C.P., Curtin J.P.: "Incisions and Wound Healing". In: Morrow C.P., Curtin J.P. (eds.), "Gynecologic Cancer Surgery". New York, Churchill Livingstone, 1996, 150.